NextCure, Inc.NextCure, Inc.NextCure, Inc.

NextCure, Inc.

No trades
See on Supercharts

NXTC fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

NextCure, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering and developing immunomedicines to treat cancer and other immune-related diseases. Its novel FIND-IO discovery technology identifies targets based on immunomodulatory function and on which the company is building a proprietary pipeline of immunomedicines. The company was founded by Michael S. Richman and Lie Ping Chen in September 2015 and is headquartered in Beltsville, MD.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
NXTC has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company